Chennai:
Demystifying
the chemical processes that create a wine's aroma, and the invaluable potential
application of that understanding in winemaking, is the new objective of
scientists in Uruguay who, with European partners, also recently sequenced the
genome of the high-value Tannat grape, from which "the most healthy of red
wines" are fermented.
Meanwhile,
a quick, $1 test being developed by researchers in Paraguay and Uruguay
promises to reduce the economic and health burden caused by syphilis -- a
dreaded sexually-transmitted disease carried today by 3 million people in Latin
America but readily treated and cured if diagnosed early.
Though
seemingly disparate, the twin breakthroughs have a common midwife: the United
Nations University's Venezuela-based BIOLAC programme, which in 2013 marks its
25th year of advancing regional economic and health interests by building
biotech science throughout Latin America and the Caribbean.
Connected at UNU-BIOLAC workshops in
Montevideo, Uruguayan chemistry professor Francisco Carrau and scientist
Massimo Delledonne of Italy recently collaborated on sequencing the Tannat
grape, pressings of which, thanks partly to its many seeds, produces the
largest concentration of tannins -- an anti-oxidant that combats the ageing of
cells.
Wines made from the Tannat are known as the most healthy of
red wines due to their high levels of procyanidins, said to be good for
reducing blood pressure, lowering cholesterol and encouraging healthy blood
clotting.
Says
Prof. Carrau: "A wine made with Tannat has twice the tannins of Cabernet
Sauvignon, Merlot or Pinot Noir.
Sequencing the grape's genome will allow vintners to protect a valuable
niche in the world's $300 billion wine industry."
Now
the same researchers are probing a secret of nature of potentially great
commercial interest as well: how soil conditions, minerals, sun, temperature,
climate, altitude and other environmental factors affect the expression of
genes in grapes and the chemistry of wine's aromas and color.
"Winemaking
has always been an art. Today it is
also a science," says Prof. Carrau.
"If we can determine through biotechnology the factors that
determine a wine's aroma and color, we can potentially apply that information
to create more pleasing and valuable products."
"Such
information can also valuably guide decisions about where to plant new vines,
which typically produce their first fruit after five years and their best fruit
in about a decade. Having the ability
to predict successful vineyard location holds enormous value."
Tannat
is the "national grape" of Uruguay, South America's 4th-largest wine
producer with 8,500 hectares (21,000 acres) of vineyards. More than a third of the grapes grown are
Tannat, from which the country's signature wines are produced.
Plantings
of Tannat (also known in Uruguay as Harriague) have been increasing each year
as that country's wine industry develops.
Though a small player still, Uruguay is a rising star in the world's
wine industry, exporting about 17% of its production (over 20 million litres
valued at $15 million in 2012; a roughly 500% jump in the value of exports from
2004).
The
main exports are Tannat or Tannat blends and vineyards in Uruguay have begun to
distinguish between "old vines" -- descendants from the original
cuttings brought over from Europe -- and new clones being produced today. The
newer vines tend to produce more powerful wines with higher alcohol levels but
less acidity, as well as more complex fruit characteristics.
A quick, $1 syphilis test to make
diagnosis readily available
Syphilis
has become, again, a serious health issue in Latin American countries with 3
million cases. Every year 330,000
pregnant women with syphilis receive no treatment resulting in 110,000 children
born with congenital syphilis and a similar number of miscarriages.
"Early
diagnosis is essential because to cure syphilis we only need penicillin. It is
very cheap, very easy. The sole challenge is to obtain immediate
diagnosis," says Monica Marín, Professor of Biochemistry and Molecular
Biology at Uruguay's University of the Republic.
Unfortunately,
she says, commercial kits for early syphilis detection are too expensive to use
in a systematic screening of all pregnancies in Latin American countries where,
in some areas, there are five new cases daily.
The
proteins needed for the test come from the bacterium that causes syphilis. And reducing the price of the tests requires
producing high volumes of these proteins, explains Dr. Marín.
That's
where UNU-BIOLAC provided help, supporting two courses in the development of
diagnosis methods and recombinant protein production and purification
processes.
"BIOLAC
was the starting point. Without them, this could not have been possible,"
says Dr. Marín.
The
courses, conducted in Paraguay, were co-organized by Graciela Velazquez and
Graciela Russomando of Paraguay and, from Uruguay, Dr. Marín and Mario
Señorale. They set a simple problem-based goal: develop a $1 dollar early
detection kit that would work as easily as popular pregnancy tests. The
syphilis test would be administered together with the pregnancy test in health
centers, allowing for immediate point of care administration of penicillin to
treat any detected infection.
Says
Dr. Marín: "Obtained via DNA technologies used in the training courses,
the proteins have proven highly sensitive and specific in detecting
syphilis. To mass produce them, we are
now using BIOLAC workshops to optimize the genetic expression and purification
experimental procedures."
No comments:
Post a Comment